David G. Hassall
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Cholesterol and Lipid Metabolism, Lipoproteins and Cardiovascular Health, Adipose Tissue and Metabolism, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid(2003)538 cited
- → Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro.(1991)327 cited
- → Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation(1989)322 cited
- → Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men(2007)317 cited
- → Triglyceride:High-Density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator Activated Receptor δ Agonist(2006)199 cited
- → The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin(1983)114 cited
- → Challenges in inhaled product development and opportunities for open innovation(2010)110 cited
- → Intracellular mechanisms in the activation of human platelets by low-density lipoproteins(1987)102 cited
- → Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells(2005)95 cited
- → Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein(1997)90 cited